Check patentability & draft patents in minutes with Patsnap Eureka AI!

Synthesis of quetiapine and pharmaceutically acceptable salts thereof

A mixture, hemi-fumarate technology, applied in the direction of active ingredients of heterocyclic compounds, organic chemistry, etc., can solve problems such as long reaction time

Inactive Publication Date: 2006-05-24
TEVA PHARMA IND LTD
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long reaction time (eg 24 hours)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis of quetiapine and pharmaceutically acceptable salts thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Reagent

[0042] 11-piperazinyldibenzo[b,f][1,4]thiazepane hydrochloride 2.75 g (7.5 mmol)

[0043] 1.2 g (9.6 mmol) of 2-(2-chloroethoxy)ethanol

[0044] Na 2 CO 3 4.75 g (45 mmol)

[0045] NaI 40-50 mg (about 0.3 mmol)

[0046] n-Butanol 15ml

[0047] TBAB 0.5g

[0048] process

[0049] The reagents were added to a round bottom flask and heated to 115°C-120°C under gentle reflux for 24 hours. Heating was discontinued, the solution was cooled, and the resulting slurry was filtered. The precipitate was washed twice with a small amount of butanol. The washings were combined with the filtrate, and the precipitate was discarded. Fumaric acid (0.435 g, 3.75 mmol) was added to the filtrate, the mixture was heated on a boiling water bath, the flask was removed from the water bath, and quindipine hemifumarate crystallized. The precipitate was collected (isolated) by filtration and recrystallized from 28 mL of ethanol to give 2.0 g of product (60.4%).

Embodiment 2

[0051] Reagent:

[0052] 11-piperazinyldibenzo[b,f][1,4]thiazepane hydrochloride 5.5 g (15 mmol)

[0053] 2-(2-Chloroethoxy)ethanol 2.4 g (19 mmol)

[0054] Na 2 CO 3 9.5 g (90 mmol)

[0055] NaI 90 mg (0.6 mmol)

[0056] 30ml n-butanol

[0057] TBAB 1 g

[0058] process:

[0059] The reagents were added to a round bottom flask equipped with a magnetic stirrer and a condenser with a calcium chloride drying tube. Place the flask in an oil bath at 115-120°C and stir the contents of the flask under gentle reflux conditions. After 24 hours of heating, the heating was stopped and the mixture was cooled and filtered. The precipitate was collected on a Buchner filter, washed twice with butanol, the washings were combined with the filtrate, and the precipitate was discarded. The filtrate was added to a reaction vessel, and fumaric acid (870 mg, 7.5 mmol) was added to the vessel, and the mixture was heated to boiling on an oil bath. The container was removed from the oi...

Embodiment 3

[0061] Reagent:

[0062] 11-piperazinyldibenzo[b,f][1,4]thiazepane hydrochloride 16.5 g (44 mmol)

[0063] 7.2 g (58 mmol) of 2-(2-chloroethoxy)ethanol

[0064] Na 2 CO 3 28.5 g (270 mmol)

[0065] NaI 270 mg (0.18 mmol)

[0066] TBAB 3 grams

[0067] Toluene 82.5ml

[0068] process:

[0069] The reagents were added to a round bottom flask equipped with a magnetic stirrer and a condenser with a calcium chloride drying tube. The flask and contents were heated in an oil bath at 105°C under gentle reflux. After heating for 24 hours, a Dean Stark trap was attached to the flask and an azeotropic mixture of water and toluene was distilled off. The product remaining in the flask was filtered off. The precipitate (salt) was washed with a small amount of toluene on a Buchner filter, the washings were combined with the filtrate, and the precipitate was discarded.

[0070] To the filtrate contained in the flask was added 2.6 g (22 mmol) of fumaric acid, the mixture was he...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
boiling pointaaaaaaaaaa
Login to View More

Abstract

The present invention provides a novel synthesis method of quindipine; quindipine and its acid addition salt prepared by the method; and a pharmaceutical composition comprising the thus prepared quindipine or its acid addition salt.

Description

[0001] related application [0002] This application claims priority to US Provisional Patent Application Serial No. 60 / 448,934, filed February 22,2003. technical field [0003] The present invention relates to the synthesis of quetiapine and its pharmaceutically acceptable salts. Background technique [0004] Quindipine, the structure of 2-(2-(4-dibenzo[b,f][1,4]thiazepan-11-yl-1-piperazinyl)ethoxy)ethanol As shown in the following formula (I). [0005] [0006] Quindipine is a psychotropic organic compound that is an antagonist of various neurotransmitter receptors in the brain. Merck Index, Edition 13, 8130 (2001). Quindipine is an antipsychotic drug that is used specifically for the treatment of schizophrenia. For example, quindipine can be prepared according to the teachings of US Patent 4,879,288, which is incorporated herein by reference. [0007] As taught in the '288 patent, quindipine can be obtained via 11-piperazinyldibenzo[b,f]-[1,4]thiazepane hydrochlor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D281/16A61K31/55
CPCC07D281/16
Inventor D·迪勒B·Z·多利茨基
Owner TEVA PHARMA IND LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More